Washington, DC (July 23, 2013)
The Personalized Medicine Coalition today held a Congressional Briefing, Personalized Medicine: How Medical Progress Happens, hosted by the Office of Senator Tom Carper (D-DE), to a standing-room-only audience, on how personalized medicine can contribute to increasing quality and decreasing overall health care cost.
Edward Abrahams, President of the Personalized Medicine Coalition, said, "PMC hopes that, even in this era of fiscal constraint, Congress will put in place policies that promote personalized medicine and encourage innovation so patients in the future enjoy better and more effective health care – at potentially lower overall cost."
To discuss the policy challenges as well as examine the role pharmaceutical and diagnostic industries can play in advancing the use of personalized medicine to improve patient care, the briefing featured the following experts:
Patient Advocate, Stephanie Haney, Lung cancer patient
Drug Developer, Stephen L. Eck, M.D., Ph.D., Vice President Oncology Medical Sciences, Astellas Pharm Global Development
Diagnostics Developer, Patrick J. Balthrop, Sr., President and Chief Executive Officer, Luminex
Physician, Amy Abernethy, M.D., Ph.D., Director, Duke Center for Learning Health Care
PMC released its Cost-containment and Deficit Reduction Policy Principles at today’s briefing.
The policy principles can be found here
About the Personalized Medicine Coalition:
The Personalized Medicine Coalition (PMC), representing innovators, scientists, patients, providers and payers, promotes the understanding and adoption of personalized medicine concepts, services and products to benefit patients and the health system. For more information about PMC, visit www.personalizedmedicinecoalition.org.
PMC members shape and advance the future of personalized medicine.